Contraception in diabetic women.
Contraceptive prescription in diabetic women with current diabetic mellitus (type I or type II) or in prediabetic women with previous gestational diabetes mellitus must consider the specific metabolic effects and risks in diabetic women. This article addresses these issues, enabling the practitioner to develop individually tailored contraceptive programs to meet the changing needs and demands of the reproductive-aged diabetic woman. If focuses on the most efficacious, reversible option available--hormonal methods and intrauterine devices--both of which have been controversial for diabetic women.
Kjos
S L
SL
Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, USA.
D003267:Contraception; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use; D003920:Diabetes Mellitus; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism / Q000503:physiopathology; D016640:Diabetes, Gestational / Q000378:metabolism / Q000517:prevention & control; D005260:Female; D006801:Humans; D007434:Intrauterine Devices; D011236:Prediabetic State / Q000378:metabolism / Q000503:physiopathology; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000378:metabolism / Q000517:prevention & control; D012307:Risk Factors
D003278:Contraceptives, Oral, Hormonal